Detalle de: Cryptic Resistance Mutations Associated With Misdiagnoses of Multidrug-Resistant Tuberculosis
| Title | Cryptic Resistance Mutations Associated With Misdiagnoses of Multidrug-Resistant Tuberculosis |
| Abstract |
Understanding why some multidrug-resistant tuberculosis cases are not detected by rapid phenotypic and genotypic routine clinical tests is essential to improve diagnostic assays and advance toward personalized tuberculosis treatment. Here, we combine whole-genome sequencing with single-colony phenotyping to identify a multidrug-resistant strain that had infected a patient for 9 years. Our investigation revealed the failure of rapid testing and genome-based prediction tools to identify the multidrug-resistant strain. The false-negative findings were caused by uncommon rifampicin and isoniazid resistance mutations. Although whole-genome sequencing data helped to personalize treatment, the patient developed extensively drug-resistant tuberculosis, highlighting the importance of coupling new diagnostic methods with appropriate treatment regimens. |
| Apa Reference | Cancino-Muñoz, I., Moreno-Molina, M., Furió, V., Goig, G.A., Torres-Puente, M., Chiner-Oms, Á., Villamayor, L.M., Sanz, F., Guna-Serrano, M.R. & Comas, I. (2019). Cryptic Resistance Mutations Associated With Misdiagnoses of Multidrug-Resistant Tuberculosis. The Journal of Infectious Diseases, 220(2), 316-320. 10.1093/infdis/jiz104 |
| Doi | 10.1093/infdis/jiz104 |
| Publication Date | 15 Apr 2019 |
| Publication Type | Article |
| Researcher | Álvaro Chiner-Oms |
| Ontology | Genome Sequencing, Mutation Analysis and design, Drug resistance |
| Research Groups | |
| Tools |
